
Lucid Diagnostics
(NASDAQ) LUCD
Lucid Diagnostics Financials at a Glance
Market Cap
$167.81M
Revenue (TTM)
$4.40M
Net Income (TTM)
$53.28M
EPS (TTM)
$-0.90
P/E Ratio
-1.43
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.25
Volume
21,422
Open
$1.25
Price
$1.25
Volume
21,422
Open
$1.25
Previous Close
$1.25
Daily Range
$1.23 - $1.27
52-Week Range
$0.95 - $1.80
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.25
Volume
21,422
Open
$1.25
Previous Close
$1.25
Daily Range
$1.23 - $1.27
52-Week Range
$0.95 - $1.80
LUCD News

LUCD Reports Results
LUCD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lucid Diagnostics
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
72
CEO
Lishan Aklog, MD
Website
www.luciddx.comHeadquarters
New York City, NY 10165, US
LUCD Financials
Key Financial Metrics (TTM)
Gross Margin
-68%
Operating Margin
-11%
Net Income Margin
-12%
Return on Equity
-331%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-69.93%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$167.81M
Shares Outstanding
131.10M
Volume
21.42K
Short Interest
0.00%
Avg. Volume
1.30M
Financials (TTM)
Gross Profit
$3.92M
Operating Income
$46.05M
EBITDA
$44.34M
Operating Cash Flow
$44.14M
Capital Expenditure
$646.00K
Free Cash Flow
$44.79M
Cash & ST Invst.
$22.36M
Total Debt
$21.25M
Lucid Diagnostics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.21M
+3.3%
Gross Profit
$706.00K
-37.9%
Gross Margin
-58.30%
N/A
Market Cap
$167.81M
N/A
Market Cap/Employee
$2.33M
N/A
Employees
72
N/A
Net Income
$10.40M
+16.0%
EBITDA
$11.54M
+5.1%
Quarterly Fundamentals
Net Cash
$23.00M
+1516.1%
Accounts Receivable
$550.00K
+1310.3%
Inventory
$856.00K
+31.5%
Long Term Debt
$1.16M
-42.5%
Short Term Debt
$23.18M
+109.7%
Return on Assets
-1.00%
N/A
Return on Invested Capital
-1.78%
N/A
Free Cash Flow
$10.92M
-3.8%
Operating Cash Flow
$10.89M
-7.1%